Indefinite Delivery Contract SPE2DP22D0009
Award Date 9/13/22
Last Date to Order 9/12/23
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- The Defense Logistics Agency Troop Support Medical awarded an indefinite delivery contract to Glaxosmithkline, LLC to supply influenza virus vaccinations. Delivery orders issued against this vehicle total over $44.5 million and require Glaxosmithkline to provide vaccines from its Research Triangle Park, North Carolina facility. Performance periods range from March 2021 to November 2021. No set-asides or subcontractors are specified. This contract aims to ensure U.S. armed forces and DLA...
- The Defense Logistics Agency Troop Support Medical awarded an Indefinite Delivery Contract to Glaxosmithkline, LLC with a potential value of $50,705,424.00 to supply influenza virus vaccines. Under this contract, three firm fixed price delivery orders were issued for a total of $33,803,616.00 to provide vaccines from Glaxosmithkline's facility in Research Triangle Park, North Carolina. The periods of performance for the delivery orders range from August 31, 2022 through February 24, 2023. The...
- This federal contract IDV was awarded by the U.S. Department of Homeland Security (DHS) to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company, to procure the antiviral medication Relenza for DHS's antiviral stockpile. The single-award contract has a ceiling value of $26,389,800 and does not have a set-aside designation. Under this IDV, DHS has issued multiple delivery orders to Glaxosmithkline for the purchase of Relenza and the related antiviral medication Zanamivir, with orders...
- This Indefinite Delivery Contract (IDC) was awarded by the Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response, to Glaxosmithkline, LLC, a foreign-owned pharmaceutical company. The contract has a ceiling value of $78,310,394.13 and a period of performance ending on July 22, 2025. The purpose of this IDC is to provide a broad range of pharmaceutical products and medical countermeasures to various federal agencies, including influenza...
- The federal contract IDV award SPE2DP24D0005 is a single award indefinite delivery contract with a ceiling value of $2,327,325.00, awarded by the Defense Logistics Agency's Medical Supply Chain to the prime contractor Glaxosmithkline, LLC, doing business as Glaxosmithkline. The contract is for the delivery of influenza virus vaccines, with a period of performance through March 12, 2025. A task order with award ID SPE2DP24D0005|SPE2DP24F3249 was issued on March 14, 2024 for a firm fixed price...
- This indefinite delivery contract (IDC) was awarded by the U.S. Department of Health and Human Services to GlaxoSmithKline Holdings (Americas) Inc. for the acquisition of Relenza to support a public health emergency response to a pandemic. The single-award IDC has a total ceiling value of $82,861,551.35 and a period of performance running from the award date of July 14, 2006 through the ultimate completion date of September 1, 2010. This contract was not set aside for any specific...
- This Indefinite Delivery Contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to the pharmaceutical company Glaxosmithkline, LLC to provide pediatric influenza vaccines for the 2024-2025 timeframe. The contract has a ceiling value of $182,592,000 and a period of performance through February 28, 2025. Glaxosmithkline, a foreign-owned for-profit organization, has extensive experience as a prime contractor providing a range of pharmaceutical products and services to...
- Glaxosmithkline, LLC holds a multiple-award Federal Supply Schedule (FSS) contract under the Pharmaceuticals and Drugs schedule (FSS-61-IB) for the provision of drugs, pharmaceuticals, and hematology-related products. Awarded by the Veterans Integrated Service Network 12 on August 1, 2022, the contract carries a ceiling value of $3.9 billion and extends through July 31, 2026. As a pharmaceutical supplier to federal agencies, Glaxosmithkline delivers a diverse portfolio of pharmaceutical products...
- The Defense Logistics Agency Troop Support Medical awarded a single-award Indefinite Delivery Contract to Seqirus USA Inc. with a potential value of $12,954,518.10 to supply influenza virus vaccinations. Under this contract, three firm fixed price delivery orders have been issued to Seqirus USA Inc. totaling $12,710,418.40 to provide influenza virus vaccinations for the 2022-2023 flu season. The delivery orders require vaccinations be delivered to Summit, New Jersey by August 31, 2022. The...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to Sanofi Pasteur Inc., a foreign-owned, for-profit manufacturer of pharmaceutical goods. The 5-year contract, valued at up to $4,023,280.80, is for the provision of Influenza Virus Vaccines in support of public health preparedness missions. Sanofi Pasteur holds multiple IDVs with various federal agencies, including the Department of Health and Human Services, Centers for Disease Control and Prevention, and...
Name | Description | Awardee | Potential Value | AwardDate | CompletionDate | Updated At |
|---|---|---|---|---|---|---|
Delivery Order SPE2DP22D0009-SPE2DP22F7791 | Glaxosmithkline, LLC | $21.0k | 9/27/22 | 4/17/23 | 9/27/22 | |
Delivery Order SPE2DP22D0009-SPE2DP22F7824 | Glaxosmithkline, LLC | $26.3k | 9/27/22 | 4/17/23 | 9/27/22 | |
Delivery Order SPE2DP22D0009-SPE2DP23F5834 | Glaxosmithkline, LLC | $39.4k | 8/29/23 | 3/18/24 | 8/29/23 | |
Delivery Order SPE2DP22D0009-SPE2DP22F7674 | Glaxosmithkline, LLC | $136.5k | 9/26/22 | 4/14/23 | 9/27/22 | |
Delivery Order SPE2DP22D0009-SPE2DP22F7817 | Glaxosmithkline, LLC | $26.3k | 9/27/22 | 4/17/23 | 9/27/22 |